vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and SM Energy Co (SM). Click either name above to swap in a different company.

SM Energy Co is the larger business by last-quarter revenue ($704.9M vs $487.7M, roughly 1.4× CLOVER HEALTH INVESTMENTS, CORP.). On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -17.3%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 12.2%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

SM Energy Company is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Denver, Colorado.

CLOV vs SM — Head-to-Head

Bigger by revenue
SM
SM
1.4× larger
SM
$704.9M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+62.0% gap
CLOV
44.7%
-17.3%
SM
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
12.2%
SM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
SM
SM
Revenue
$487.7M
$704.9M
Net Profit
$-49.3M
Gross Margin
Operating Margin
-10.1%
25.9%
Net Margin
-10.1%
Revenue YoY
44.7%
-17.3%
Net Profit YoY
-123.2%
EPS (diluted)
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SM
SM
Q4 25
$487.7M
$704.9M
Q3 25
$496.6M
$811.6M
Q2 25
$477.6M
$792.9M
Q1 25
$462.3M
$844.5M
Q4 24
$337.0M
$852.0M
Q3 24
$331.0M
$643.6M
Q2 24
$356.3M
$634.6M
Q1 24
$346.9M
$559.9M
Net Profit
CLOV
CLOV
SM
SM
Q4 25
$-49.3M
Q3 25
$-24.4M
$155.1M
Q2 25
$-10.6M
$201.7M
Q1 25
$-1.3M
$182.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
$240.5M
Q2 24
$7.4M
$210.3M
Q1 24
$-19.2M
$131.2M
Gross Margin
CLOV
CLOV
SM
SM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
SM
SM
Q4 25
-10.1%
25.9%
Q3 25
-4.9%
30.4%
Q2 25
-2.2%
37.2%
Q1 25
-0.3%
32.7%
Q4 24
-6.4%
33.7%
Q3 24
-2.7%
51.4%
Q2 24
2.0%
44.0%
Q1 24
-6.5%
31.9%
Net Margin
CLOV
CLOV
SM
SM
Q4 25
-10.1%
Q3 25
-4.9%
19.1%
Q2 25
-2.2%
25.4%
Q1 25
-0.3%
21.6%
Q4 24
-6.6%
Q3 24
-2.8%
37.4%
Q2 24
2.1%
33.1%
Q1 24
-5.5%
23.4%
EPS (diluted)
CLOV
CLOV
SM
SM
Q4 25
$0.94
Q3 25
$1.35
Q2 25
$1.76
Q1 25
$1.59
Q4 24
$1.63
Q3 24
$2.09
Q2 24
$1.82
Q1 24
$1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SM
SM
Cash + ST InvestmentsLiquidity on hand
$78.3M
$368.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$4.8B
Total Assets
$541.0M
$9.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SM
SM
Q4 25
$78.3M
$368.0M
Q3 25
$162.3M
Q2 25
$101.9M
Q1 25
$54.0K
Q4 24
$194.5M
Q3 24
$288.0M
$1.7B
Q2 24
$254.8M
$487.9M
Q1 24
$208.3M
$506.3M
Stockholders' Equity
CLOV
CLOV
SM
SM
Q4 25
$308.7M
$4.8B
Q3 25
$340.9M
$4.7B
Q2 25
$344.2M
$4.6B
Q1 25
$336.1M
$4.4B
Q4 24
$341.1M
$4.2B
Q3 24
$342.2M
$4.1B
Q2 24
$324.9M
$3.8B
Q1 24
$292.5M
$3.7B
Total Assets
CLOV
CLOV
SM
SM
Q4 25
$541.0M
$9.3B
Q3 25
$559.7M
$9.1B
Q2 25
$575.0M
$9.0B
Q1 25
$583.7M
$8.8B
Q4 24
$580.7M
$8.6B
Q3 24
$653.0M
$8.0B
Q2 24
$674.2M
$6.7B
Q1 24
$671.8M
$6.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SM
SM
Operating Cash FlowLast quarter
$-66.9M
$451.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SM
SM
Q4 25
$-66.9M
$451.9M
Q3 25
$12.1M
$505.0M
Q2 25
$5.4M
$571.1M
Q1 25
$-16.3M
$483.0M
Q4 24
$34.8M
$578.4M
Q3 24
$50.0M
$452.3M
Q2 24
$44.8M
$476.4M
Q1 24
$25.9M
$276.0M
Free Cash Flow
CLOV
CLOV
SM
SM
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
SM
SM
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
SM
SM
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
SM
SM
Q4 25
Q3 25
3.26×
Q2 25
2.83×
Q1 25
2.65×
Q4 24
Q3 24
1.88×
Q2 24
6.04×
2.27×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons